Gilead should give up FDA voucher for remdesivir, patient advocates say

Advocacy group Public Citizen wrote to Gilead asking it to give up a voucher given to it by the FDA when granted approval for remdesivir, arguing that the voucher is "an entirely unnecessary and inappropriate incentive" for the drug, which has already generated millions of dollars for the drugmaker.